WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Broadens Healthcare Access: Foreign Doctors and Drug Import Reforms in N... On April 21, China's State Council unveiled a comprehensive plan to further open its service sector, with a significant focus on healthcare reforms. The ini...
(4/22/2025)

China Aims for Significant Pharma Industry Dig... (4/26/2025)

MNC Pharma's Q1/2025 China Performance: Diverg... (4/25/2025)

Cell Therapy to AI: How J&J Has Been Sourcing ... (4/25/2025)

China Biopharma Tracker – March 2025 (PharmaD... (4/24/2025)

US Capital Crunch Pushes China Biotechs to Rou... (4/24/2025)

Cheaper Chinese HPV Vaccines Turn Merck's Gard... (4/23/2025)

China Broadens Healthcare Access: Foreign Doct... (4/22/2025)

As US Decouples, China Strengthens Biotech Tie... (4/22/2025)

Chinese drugmakers weigh options as US mulls p... (4/18/2025)

Interpretation of the Anti-Monopoly Guidelines... (4/17/2025)

This Pharma Company Is Betting Big On A Chines... (4/17/2025)

Off-Label Drug Use in China After the Physicia... (4/15/2025)

Recent Executive Moves (4/26/2025) China's Innovative Drug Licensing Deals ... (4/25/2025) China Greenlights Recordati's Long-Actin... (4/25/2025) Akeso's Ivonescimab Gains Second Approva... (4/25/2025) Akeso's Penpulimab Secures FDA Approval ... (4/25/2025) NMPA Approves Expanded Use of JNJ's Rybr... (4/25/2025) China's Fast-Track Drug Approvals Accele... (4/25/2025) AstraZeneca China Announces Major Reorga... (4/25/2025) JIBP Aims for Hong Kong IPO amid Biophar... (4/25/2025) Akeso's Ivonescimab Outperforms Tisleliz... (4/24/2025) LTZ Thera Secures $40M in Oversubscribe... (4/24/2025) Merck's Gardasil Sales Plunge Amid China... (4/24/2025) Bayer Pharma Accelerates Growth in China... (4/24/2025) Ascletis Challenges Lilly, Novo With Pro... (4/24/2025) Global Pharma Feels 'Sense of Urgency' t... (4/23/2025) China Accelerates Development of Multiva... (4/23/2025) Carbogen Amcis Secures Chinese Drug Manu... (4/22/2025) Fujifilm Capitalizes on U.S.-China Tensi... (4/22/2025)

China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-... China's Retail Pharmacy Market Reaches CNY 574 Billion ... China's Pharmaceutical Market Shrinks in 2024 Amid Stru...

JIBP Aims for Hong Kong IPO amid Biopharma Market Reviv... AstraZeneca China Announces Major Reorganization to Bol... China's Fast-Track Drug Approvals Accelerating Access t... China's Innovative Drug Licensing Deals Soar, Big Pharm... Ascletis Challenges Lilly, Novo With Promising Oral GLP...

CDE Issues the List of Reference Formulations for GQCE ... China Seeks Feedback on ICH Draft Guideline M13B for Bi... China Issues New Guidelines to Streamline Mainland Regi... China Revises Military Drug Administration Measures to ... CDE Solicits Comments on Draft Q&A for CMC Issues in r...

NHC Ministers Meet with Top Pharma MNC Executives Beijing Unveils Ambitious Policy Package to Supercharge... China's BMI Fund Surpasses CNY16.5 Trillion with 11% An... Growing Awareness and Expanding Treatment Options for S... China Sets Ambitious Nutritional Targets for 2030 to Im...

Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t... Bayer Initiates Patent Infringement Lawsuit Against Hen... Oxford Nanopore Sues Chinese Biotech Giant BGI Over All... Congress Debates Biosecure Act Amid Report Highlighting...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

NMPA Approves Expanded Use of JNJ's Rybrevant for Advan... Akeso's Penpulimab Secures FDA Approval for Nasopharyng... Akeso's Ivonescimab Gains Second Approval in China China Greenlights Recordati's Long-Acting Pasireotide f... Akeso's Ivonescimab Outperforms Tislelizumab in Phase I...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...